Efficacy and toxicity of anti-CD40 monoclonal antibodies in the treatment of malignancy

Efficacy and toxicity of anti-CD40 monoclonal antibodies in the treatment of malignancy

Bibliographic Details
Main Author:	Geldart, Thomas Richard
Published:	University of Southampton 2004
Subjects:	616.9940798
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.403845

Similar Items

The role of CD40 and CD137 in immune responses to cancer : a study of monoclonal antibody mediated immunomodulation in two murine tumour models
by: Green, Michael
Published: (2003)

Assessment of Anti-CD40 Monoclonal Antibodies as Novel Immunological Adjuvants in Conjuate Vaccines
by: Prasad, Vijay Narayana Sharma Bhagawati
Published: (2008)

Mechanisms of action of non-depleting anti-CD4 monoclonal antibodies
by: Fehérvári, Zoltán Tamás
Published: (2000)

Signalling cascades induced by type I and II anti-CD20 monoclonal antibodies
by: Walshe, Claire Anne
Published: (2006)

T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody
by: Tutt, Alison L., et al.
Published: (2002)

Assessment of anti- CD40 monoclonal antibodies as novel immunological adjuvants in conjugate vaccines
by: Heath, Andrew
Published: (2008)

Precision Medicine in Graves’ Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal Antibody
by: Larissa C. Faustino, et al.
Published: (2021-06-01)

Experimental and clinical studies on the imunosuppressive and toxic effects of anti-CD3 monoclonal antibodies
by: Wissing, Karl Martin
Published: (2000)

Immunotherapy of murine B-cell lymphoma mediated by agonistic anti-CD40 antibody : role of co-stimulation in generation of CD8âº CDL
by: Crowther, Graham Roy
Published: (2004)

Monoclonal antibody therapy of multiple sclerosis
by: Coles, A.
Published: (1998)

Isatuximab, a novel anti-CD38 monoclonal antibody in the treatment of multiple myeloma: efficacy and safety
by: Karina E. Zatolochina, et al.
Published: (2021-08-01)

Defining the use of anti-PrP monoclonal antibodies in a mouse model of prion disease
by: Carswell, C.
Published: (2011)

Ofatumumab: a novel monoclonal anti-CD20 antibody
by: Thomas S Lin
Published: (2010-05-01)

Application of anti-CD20 monoclonal antibodies in the treatment of lymphoproliferative diseases
by: Pejčić Ivica, et al.
Published: (2009-01-01)

Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant.
by: Cameron Martin, et al.
Published: (2017-01-01)

Human lymphoid cell immunophenotypes : in situ immunochemistry of human lymphoid tissue, benign and malignant cutaneous lymphohistiocytic infiltrates with monoclonal antibodies
by: McMillan, Euan Murray
Published: (1990)

The development of monoclonal antibodies towards the glycoproteins of the human pneumoviruses
by: Robinson, Mark James
Published: (2007)

Proteolytic degradation of monoclonal antibodies produced in Nicotiana tabacum
by: Hehle, Verena Kerstin
Published: (2012)

The manipulation of cellular immunity by monoclonal antibodies in cancer patients
by: Hollingworth, James
Published: (1994)

A study of signal transduction events involved in anti CD40 therapy of lymphoma
by: Mann, Jelena
Published: (2001)

The production of monoclonal antibodies for the rapid diagnosis of tinea capitis infections
by: Ballsdon, Annabelle Elizabeth
Published: (2004)

Production and molecular characterization of monoclonal antibodies against rabies virus
by: Both, Leonard
Published: (2013)

Investigating the solution conformations of IgG subclass monoclonal antibodies
by: Longman, Emma
Published: (2005)

The expression and detection of Escherichia coli lipopolysaccharide with monoclonal antibody probes
by: Nelson, David
Published: (1991)

The role of EGR-1 and calcium influx in the antitumor activity of anti-CD20 monoclonal antibodies
by: Spasevska, Ivana
Published: (2017)

The perfusion of renal allografts with anti-CD45 monoclonal antibodies
by: Goldberg, Lawrence
Published: (1987)

Lenalidomide and the new-generation anti-CD20 antibodies in mantle cell lymphoma
by: Eve, Heather E.
Published: (2012)

Resolution of Q Fever–Associated Cryoglobulinemia With Anti-CD20 Monoclonal Antibody Treatment
by: Kellie L. Hawkins MD, MPH, et al.
Published: (2017-01-01)

Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
by: Mihaljević Biljana, et al.
Published: (2008-01-01)

Studies of the conserved neutralising epitopes of human rhinoviruses using monoclonal antibodies
by: Kumar, Arvind
Published: (1989)

New ultra scale-down principles for monoclonal antibody recovery and purifications
by: Hutchinson, N.
Published: (2007)

Delineating the apoptotic mechanisms of an anti-CD19 immunotoxin used in combination with the anti-CD20 antibody rituximab against human B-lymphoma cells
by: Bryson, Christine Jane
Published: (2004)

CD40 Agonist Monoclonal Antibody-Mediated Hepatitis in TNF-Receptor 1 Gene Knockout Mice
by: Oksana Raabe, et al.
Published: (2021-07-01)

Preclinical Immunopharmacologic Assessment of KPL-404, a Novel, Humanized, Non-Depleting Antagonistic Anti-CD40 Monoclonal Antibody
by: Bondensgaard, K., et al.
Published: (2022)

The role of platelet CD40L in inflammation
by: Inwald, David Philip
Published: (2004)

The development and evaluation of novel monoclonal antibodies directed against folate pathway components
by: Quinn, Amy Elizabeth
Published: (2012)

Cardiac toxicity with monoclonal antibodies therapy
by: Haitham Mazek, et al.
Published: (2015-07-01)

Production and Characterization of New Anti-Human CD20 Monoclonal Antibody
by: Mahdi Fasihi-Ramandi, et al.
Published: (2015-10-01)

Transfusion management for patients taking an anti-CD38 monoclonal antibody
by: Carolina Bonet Bub, et al.
Published: (2018-01-01)

Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo
by: Logan Banadyga, et al.
Published: (2019-06-01)

Cannot write session to /tmp/vufind_sessions/sess_fpq150bceo4aitlvbremodlu1l